Staphylococcal scalded skin syndrome in an older infant
Main Article Content
Abstract
Background: Staphylococcal scalded skin syndrome (SSSS) is a rare condition, characterized by skin sputtering resulting from the action of exfoliative toxins (ET) produced by Staphylococcus aureus. The therapy consists on specific antibiotics and supportive treatment with interdisciplinary management.
Clinical case: We present the case of an older infant admitted with bullous lesions and skin disruption of short evolution that begins in the genital region, with progression and compromise of 40% of total body surface requiring management in the pediatric intensive care unit (PICU).
Conclusion: SSSS despite being an infrequent disease, presents a characteristic clinical feature that allows pediatricians to differentiate it from other infectious pathologies of the skin, and thus make an early diagnosis.
Downloads
Article Details
Creative Commons
License Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0)
You are free to:
Share - copy and redistribute the material in any medium or format.
Adapt - remix, transform, and build upon the material The licensor cannot revoke these freedoms as long as you follow the license terms.
• Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
• NonCommercial — You may not use the material for commercial purposes.
• ShareAlike — If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original.
• No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
References
2. Staiman A, Hsu D, Silverberg J. Epidemiology of Staphylococcal Scalded Skin Syndrome in United Stated Children. Br J Dermatol. 2018;178(3):704–8.
3. Stanley JR, Amagai M. Pemphigus, Bullous Impetigo, and the Staphylococcal Scalded-Skin Syndrome. N Engl J Med. 2006;355(17):1800–10.
4. Handler MZ, Schwartz RA. Staphylococcal scalded skin syndrome: diagnosis and management in children and adults. J Eur Acad Dermatology Venereol. 2014;28(11):1418–23.
5. Kouakou K, Dainguy ME, Kassi K. Staphylococcal Scalded Skin Syndrome in Neonate. Case Rep Dermatol Med. 2015;2015:1–4.
6. Yamasaki O, Yamaguchi T, Sugai M, Chapuis-Cellier C, Arnaud F, Vandenesch F, et al. Clinical manifestations of staphylococcal scalded-skin syndrome depend on serotypes of exfoliative toxins. J Clin Microbiol. 2005;43(4):1890–3.
7. Dancer SJ, Garratt R, Saldanha J, Jhoti H, Evans R. The epidermolytic toxins are serine proteases. FEBS Lett. 1990;268(1):129–32.
8. Mishra AK, Yadav P, Mishra A. A Systemic Review on Staphylococcal Scalded Skin Syndrome (SSSS): A Rare and Critical Disease of Neonates. Open Microbiol J. 2016;10(1):150–9.
9. Amagai M, Matsuyoshi N, Wang ZH, Andl C, Stanley JR. Toxin in bullous impetigo and staphylococcal scalded-skin syndrome targets desmoglein 1. Nat Med. 2000;6(11):1275–7.
10. Amagai M, Yamaguchi T, Hanakawa Y, Nishifuji K, Sugai M, Stanley JR. Staphylococcal exfoliative toxin B specifically cleaves desmoglein 1. J Invest Dermatol. 2002;118(5):845–50.
11. Ladhani S. Recent developments in staphylococcal scalded skin syndrome. Clin Microbiol Infect. 2001;7(6):301–7.
12. Grama A, Mărginean OC, Meliț LE, Georgescu AM. Staphylococcal Scalded Skin Syndrome in Child. A Case Report and a Review from Literature. J Crit Care Med. 2016;2(4):192–7.
13. Blyth M, Estela C, Young AER. Severe staphylococcal scalded skin syndrome in children. Burns. 2008;34(1):98–103.
14. Gil F, Herranz M, Durán G, Zandueta I, Gimeno J, Bernaola E. Clindamicina como terapia adyuvante en el síndrome de piel escaldada estafilocócica. An Sist Sanit Navar. 2014;37(3):580–7.
15. Braunstein I, Wanat KA, Abuabara K, McGowan KL, Yan AC, Treat JR. Antibiotic sensitivity and resistance patterns in pediatric staphylococcal scalded skin syndrome. Pediatr Dermatol. 2014;31(3):305–8.